---
$id: https://graph.org.ai/products/commodity/51141571
$type: Product
source: UNSPSC
code: "51141571"
title: "Phensuximide"
class: "51141500"
classTitle: "Anticonvulsants"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Phensuximide

**UNSPSC Code**: 51141571
**Class**: [Anticonvulsants](Anticonvulsants.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticonvulsant agent with the molecular formula C11H11NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6WVL9C355G, chemically known as 2,5-pyrrolidinedione, 1-methyl-3-phenyl- but generally known as phensuximide, which bears US NIH Compound Identifier 6839. European Medicines Agency schedules Phensuximide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09783MIG. The term PHENSUXIMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). World Health Organization schedules phensuximide in its Anatomical Therapeutic Chemical (ATC) Classification. PHENSUXIMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule phensuximide under HS 29251995 and SITC 51482. As of Q4 2014, PHENSUXIMIDE remains the US FDA Preferred Term for this commodity. Phensuximide bears US NLM identifiers UMLS ID C0070592 and NCI Concept Code C66375. SMILES: CN1C(=O)CC(C1=O)C2=CC=CC=C2.

